天然产物研究与开发 ›› 2021, Vol. 33 ›› Issue (3): 490-499.doi: 10.16333/j.1001-6880.2021.3.017

所属专题： No.1

• 数据研究 • 上一篇    下一篇

当归芍药散对新型冠状病毒肺炎的临床疗效及其作用机制的网络药理学研究

刘宇寒，潘广涛，尚罗锐，周方园，杨胜兰*   

  1. 华中科技大学同济医学院附属协和医院中西医结合科，武汉 430000
  • 出版日期:2021-03-28 发布日期:2021-04-01
  • 基金资助:
    湖北省重点研发计划（2020BCA065）；国家自然科学基金（81673760，81874397）

Clinical efficacy of Danggui Shaoyao Power in COVID-19 and network pharmacology study of its mechanism

LIU Yu-han,PAN Guang-tao,SHANG Luo-rui,ZHOU Fang-yuan,YANG Sheng-lan*   

  1. Department of Integrated Traditional Chinese and Western Medicine,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430000,China

  • Online:2021-03-28 Published:2021-04-01

PDF (PC)

82

摘要： 为探讨当归芍药散对新型冠状病毒肺炎（COVID-19）的临床疗效及其作用机制，随机选取2020年1月20日~3月20日武汉协和医院收治的100例COVID-19患者作为研究对象，观察当归芍药散联合常规治疗前后患者的基本体征、主要症状、实验室指标、核酸转阴、CT影像学的变化情况，发现以上症状及指标均较前明显好转。同时运用网络药理学分析当归芍药散治疗COVID-19的潜在作用靶点，得到作用靶点18个，GO功能富集180条目，KEGG通路富集109条。结果提示当归芍药散可能通过多靶点、多通路发挥抗病毒、抗炎、抗氧化等作用，进而达到治疗COVID-19的效果。

关键词: 网络药理学, 当归芍药散, 新型冠状病毒肺炎, 机制

Abstract:

To explore the clinical efficacy and mechanism of Danggui Shaoyao Powder in coronavirus disease 2019 (COVID-19),we collected and analyzed the clinical data containing basic signs,main symptoms,laboratory indicators,nucleic acid negative conversion,and CT imaging before and after Danggui Shaoyao Powder combined with conventional treatment of 100 COVID-19 patients admitted to Wuhan Union Hospital from January 20 to March 20,2020.The results showed that the clinical symptoms and laboratory indicators of these patients were significantly better than before.At the same time,we analyzed the potential targets of Danggui Shaoyao Powder in the treatment of COVID-19 through network pharmacology.Then we found 18 targets,180 items of GO function enrichment,and 109 items of KEGG pathway enrichment.The results suggested that Danggui Shaoyao Powder exerted its therapeutic effects in COVID-19 by modulating multiple targets and pathways,including anti-virus,anti-inflammation,and anti-oxidation.

Key words: network pharmacology, Danggui Shaoyao Power, COVID-19, mechanism

中图分类号:  R285.5

版权所有 © 《天然产物研究与开发》编辑部
地址：四川天府新区群贤南街289号　邮编：610299
电话：028-85210304　QQ群：342035423　Email：trcw@clas.ac.cn; re_trcw@clas.ac.cn　
本系统由北京玛格泰克科技发展有限公司设计开发
总访问量：　今日访问：　在线人数：